相似文献
1
[The pharmacology of estrogens].
Pharm Unserer Zeit. 2004;33(5):360-4. doi: 10.1002/pauz.200400082.
2
[The modulators of the estrogenic activity].
Ann Pharm Fr. 2000 Dec;58(6):383-91.
3
[The molecular mechanisms of estrogens. Clinical aspects, industrial estrogens and phytoestrogens].
Ugeskr Laeger. 2004 Mar 22;166(13):1220-4.
4
[Estrogenic and antiestrogenic preparations--pharmacological and clinical aspects].
Akush Ginekol (Sofiia). 1985;24(4):19-22.
5
Effect of estrogens on skin aging and the potential role of selective estrogen receptor modulators.
Climacteric. 2007 Aug;10(4):289-97. doi: 10.1080/13697130701467157.
6
Estrogen receptor ligands. Part 13: Dihydrobenzoxathiin SERAMs with an optimized antagonist side chain.
Bioorg Med Chem Lett. 2005 Sep 1;15(17):3912-6. doi: 10.1016/j.bmcl.2005.05.089.
7
The stability of the uterine estrogen receptor when complexed with estrogens or antiestrogens.
Mol Pharmacol. 1980 Nov;18(3):406-12.
8
Signaling by estrogens.
J Cell Physiol. 2007 Dec;213(3):610-7. doi: 10.1002/jcp.21253.
9
Are the differences between estradiol and other estrogens, naturally occurring or synthetic, merely semantical?
J Clin Endocrinol Metab. 1996 Feb;81(2):850-1. doi: 10.1210/jcem.81.2.8636315.
10
New estrogenic antagonists bearing dicarba-closo-dodecaborane as a hydrophobic pharmacophore.
Chem Pharm Bull (Tokyo). 2000 Feb;48(2):312-4. doi: 10.1248/cpb.48.312.
Zotero 插件